• Search by category

  • Show all

Coming soon - 12 Days of Nichemas

November 12, 2016
 - Tim Hardman

Did we mention that we love to share? We post news about science progress every day on our company LinkedIn page — do you follow us? We've shared more than 7,680 news stories in the last 3 years. In most cases, these have been stories that interested us at Niche. Many of you have been kind enough to give us feedback on our work. The people who have done this range from high school teachers who use the stories with their students to senior executives in the pharmaceutical business who read them to keep up with medical advances. You may also know about FYI-news, our news service. Here, we go into a little more depth about the stories that the Niche team is most interested in.

Since 2013, our Insider's Insights have been a way for friends and clients to get our thoughts on important topics. A lot of you may have seen them. In earlier editions, topics have included everything from how to plan a clinical study to how to make professional posters. We have 18 years of experience in this field and have put together this information. These documents are the result of a lot of work and knowledge. We are quite proud of the fact that we have included everything we have learned while working in the field in this paper. These are not the ‘minimal content’ marketing vehicles with too-enticing names that you are usually pushed as part of an exercise called content-driven marketing, which is not what it is. We have taken to heart that content marketing is not the publishing of a thin piece of opinion that offers little value. Our focus is on making valuable materials our clients and audience can discover for themselves while they browse.

Since we care about each of our Insider's Insights, we don't share them until most of our team has had a chance to comment on them. We hope that these papers will be useful to you for many years to come. A lot of you have been kind enough to tell us what we should write about in future issues.

At Christmas, we like to thank our friends and coworkers for the great times we've had together in 2016. As part of our holiday wishes, we will be sending out nine of our newest Insider's Insights. To mix things up a bit, we will also be adding three ALL-NEW Insider's Insights. Everyone is welcome to join our "12 Days of Niche-mas" celebration, where we will share a new Insider's Insight every day. We want these papers to be available to as many people as possible. Don't worry—registering doesn't mean Niche will send you a bunch of other marketing tasks; we'll only use your information to send you our Insider's Insights. Also, we won't give your information to anyone else, so don't worry about getting more spam.

About the author

Tim Hardman
Managing Director
View profile
Dr Tim Hardman is Managing Director of Niche Science & Technology Ltd., a bespoke services CRO based in the UK. He also serves as Managing Director at Thromboserin Ltd., an early-stage biotechnology company. Dr Hardman is a keen scientist and an occasional commentator on all aspects of medicine, business and the process of drug development.

Related Articles

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility